II. Indications
- See Second Generation Broad-spectrum Cephalosporin
- Conditions
- Respiratory tract infections
- Community Acquired Pneumonia
- Urinary Tract Infection
- Skin and Soft Tissue Infection
- Otitis Media (second-line)
- Acute Sinusitis (second-line)
- Streptococcal Pharyngitis (second-line)
- No significant CSF penetration
- Cefuroxime as an exception does penetrate CSF, but less than Third Generation Cephalosporins
-
Antibiotic Coverage Spectrum
- Gram Positive Cocci
- EKP Gram Negative Bacteria
- Gram Negative Coccobacilli
- No significant anaerobic coverage
III. Medications: Available in U.S.
-
Cefprozil (Cefzil)
- Adult: 250 to 500 mg orally divided daily to twice daily
- Child
- Otitis Media: 15 mg/kg/dose orally twice daily
- Pharyngitis: 7.5 mg/kg/dose orally twice daily for 10 days
-
Cefuroxime (Ceftin, Zinacef)
- Adult
- Parenteral: 750 to 1500 mg IM or IV every 8 hours
- Oral: 250 to 500 mg orally twice daily
- Child
- Parenteral: 50-100 mg/kg/day IV divided every 6-8 hours
- Oral: 20-30 mg/kg/day orally divided twice daily
- Reported to have unpleasant taste
- Directions
- Take with food
- Adult
IV. Medications: Discontinued in U.S. (or avoided)
- Loracarbef (Lorabid)
- Listed for historical reasons
- Discontinued in U.S. in 2006
- Adult: 200 to 400 mg orally twice daily
- Child
- Otitis Media: 30 mg/kg/day divided bid
- Other infections: 15 mg/kg/day divided bid
- Directions
- Take more than 1 hour before or 2 hours after food
- Cefaclor (Ceclor)
- Listed for historical reference only
- Risk of significant serum-sickness type reaction
- Adult: 250 to 500 mg orally three times daily
- Child: 20 to 30 mg/kg/day (maximum 1 g/day) orally divided three times daily
Images: Related links to external sites (from Bing)
Related Studies
cefaclor (on 11/23/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
CEFACLOR 250 MG CAPSULE | Generic | $1.00 each |
CEFACLOR 500 MG CAPSULE | Generic | $0.89 each |